Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 350

1.
2.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

Case DC Jr, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, et al.

J Natl Cancer Inst. 1993 May 19;85(10):801-6.

PMID:
8487324
[PubMed - indexed for MEDLINE]
3.

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW, Fritz E.

Cancer. 1995 Dec 1;76(11):2319-29.

PMID:
8635038
[PubMed - indexed for MEDLINE]
4.

The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.

Malik IA, Khan ZK, Hakimali A, Sabih M, Rehman G.

J Pak Med Assoc. 1998 May;48(5):127-31.

PMID:
9813972
[PubMed - indexed for MEDLINE]
5.

Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.

Ayash LJ, Elias A, Hunt M, Demetri G, Wheeler C, Tepler I, Schwartz G, Mazanet R, Reich E, McCauley M, et al.

Br J Haematol. 1994 May;87(1):153-61.

PMID:
7947240
[PubMed - indexed for MEDLINE]
6.

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.

Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.

Blood. 1995 Dec 15;86(12):4446-53.

PMID:
8541533
[PubMed - indexed for MEDLINE]
Free Article
7.

Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.

Varan A, Büyükpamukçu M, Kutluk T, Akyüz C.

Pediatrics. 1999 Feb;103(2):E16.

PMID:
9925862
[PubMed - indexed for MEDLINE]
8.
9.

High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients.

Pavese I, Satta F, Todi F, Di Palma M, Piergrossi P, Migliore A, Piselli P, Borghesi R, Mancino G, Brunetti E, Alimonti A.

Ann Oncol. 2010 Jul;21(7):1523-8. doi: 10.1093/annonc/mdp568. Epub 2009 Dec 23.

PMID:
20032122
[PubMed - indexed for MEDLINE]
Free Article
10.

Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.

de Campos E, Radford J, Steward W, Milroy R, Dougal M, Swindell R, Testa N, Thatcher N.

J Clin Oncol. 1995 Jul;13(7):1623-31.

PMID:
7602351
[PubMed - indexed for MEDLINE]
11.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, Osterborg A, Repetto L, Soubeyran P; European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly.

Eur J Cancer. 2007 Jan;43(2):258-70. Epub 2006 Dec 19. Review.

PMID:
17182241
[PubMed - indexed for MEDLINE]
12.

Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.

Massa E, Madeddu C, Lusso MR, Gramignano G, Mantovani G.

Crit Rev Oncol Hematol. 2006 Feb;57(2):175-82. Epub 2005 Oct 6.

PMID:
16213740
[PubMed - indexed for MEDLINE]
13.

Prediction of response to erythropoietin treatment in chronic anemia of cancer.

Ludwig H, Fritz E, Leitgeb C, Pecherstorfer M, Samonigg H, Schuster J.

Blood. 1994 Aug 15;84(4):1056-63.

PMID:
7741835
[PubMed - indexed for MEDLINE]
Free Article
14.

Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy.

Cazzola M, Ponchio L, Pedrotti C, Farina G, Cerani P, Lucotti C, Novella A, Rovati A, Bergamaschi G, Beguin Y.

Haematologica. 1996 Sep-Oct;81(5):434-41.

PMID:
8952157
[PubMed - indexed for MEDLINE]
Free Article
15.

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.

Ahluwalia N, Skikne BS, Savin V, Chonko A.

Am J Kidney Dis. 1997 Oct;30(4):532-41.

PMID:
9328369
[PubMed - indexed for MEDLINE]
16.

Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.

Kurz Ch, Marth Ch, Windbichler G, Lahousen M, Medl M, Vavra N, Sevelda P.

Gynecol Oncol. 1997 Jun;65(3):461-6.

PMID:
9190976
[PubMed - indexed for MEDLINE]
17.

Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.

Zarogoulidis K, Papagiannis A, Ziogas E, Fahantidou E, Dermitzakis G, Gioulekas D, Vamvalis C.

Eur J Cancer. 1997 Dec;33(14):2428-31.

PMID:
9616293
[PubMed - indexed for MEDLINE]
18.

Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.

Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Rorive G, Fillet G.

Blood. 1993 Oct 1;82(7):2010-6.

PMID:
8400253
[PubMed - indexed for MEDLINE]
Free Article
19.

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.

Cascinu S, Fedeli A, Del Ferro E, Luzi Fedeli S, Catalano G.

J Clin Oncol. 1994 May;12(5):1058-62.

PMID:
8164030
[PubMed - indexed for MEDLINE]
20.

Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.

Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A.

Acta Haematol. 1997;98(4):204-10.

PMID:
9401498
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk